Company profile
Carmot Therapeutics, Inc.
- Industry
- Biotechnology Research
- Employees
- 5
- Headquarters
- Berkeley
- Office locations
- 1
Carmot Therapeutics, Inc. company summary
Carmot Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Berkeley. On LinkedIn the company has around 5 employees. Its listed specialties include Pharmaceuticals.
What technology does Carmot Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Carmot Therapeutics, Inc.
Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.
Specialties
Where is Carmot Therapeutics, Inc. located?
Carmot Therapeutics, Inc. lists 1 location.
Compare companies similar to Carmot Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Carmot Therapeutics, Inc. carmot-therapeutics.us | Biotechnology Research | 5 | - | Berkeley |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Carmot Therapeutics, Inc.
What does Carmot Therapeutics, Inc. do?
Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.
How many employees does Carmot Therapeutics, Inc. have?
Carmot Therapeutics, Inc. has around 5 employees on LinkedIn.
Where is Carmot Therapeutics, Inc. headquartered?
Carmot Therapeutics, Inc. is headquartered in Berkeley.
Build a lead list from companies like Carmot Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.